Arkolith/Insider Trading/PVLA/Form 4

Goin Kathleen

Chief Operating OfficerPALVELLA THERAPEUTICS, INC. (PVLA) · full profile →Form 4 · filed Dec 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$415K
Net Open-Market Flow
-$415K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2025Option exercise(M)2K$7.14$15K2K
Dec 17, 2025Option exercise(M)2K$9.08$20K4K
Dec 17, 2025Sell(S)4K$96.47$415K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 17, 2025Option exercise(M)2K—$021K
Dec 17, 2025Option exercise(M)2K—$022K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-123109) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML